Skip to main content
. 2020 Dec 16;37(4):e2020009. doi: 10.36141/svdld.v37i4.10726

Table 1.

Summary of Questionnaires used in Study

Title of questionnaire Questionnaire version Invitation distribution Sarcoidosis patient group Control group Dates of Survey Method of capture Comments
UC/AMC UC/AMC English Posted on FSR website and all patients see at Cincinnati clinic World wide including Cincinnati OH USA Cincinnati OH USA 4/1/2020 to 7/1/2020 REDCap For those in USA, state also indicated
FSR UC/AMC English Invitation to those in FSR registry World wide N/A 4/6/2020 to 7/1/2020 SurveyMonkey
Dutch Dutch version UC/AMC Members of Sarcoidose.nl, and advertisement at the ILD Center of Excellence, Nieuwegein, the Netherlands Netherlands N/A 6/29/2020 to 7/29/2020 SurveyMonkey Collected also if on no medication for sarcoidosis and patient’s BMI
Italian Italian version of UC/AMC e-mail contacts of the Italian Association for Sarcoidosis patients (ACSI) Italy N/A 4/1/2020 to 7/1/2020 Google Forms
Spanish Spanish version of UC/AMC recruited through membership of the Spanish association of patients with sarcoidosis (ANES-Asociación Española de) using e-mail contact Spain N/A May 2020 Google Forms

UC/AMC: University of Cincinnati/Albany Medical Center; FSR: Foundation for Sarcoidosis Research; N/A: not available; ild care: interstial lung disease care; BMI: body mass index

REDcap: Research electronic data capture https://redcap.research.cchmc.org/

SurveyMonkey: www.surveymonkey.com

Google Forms: https://www.google.com/intl/en-US/forms/about/